Search filters

List of works by Mohamed Hassany

Antiretroviral therapy under the wing of the COVID-19 epidemic: One look, and different solutions

scientific article published on 15 December 2020

Assessment of the Relation Between SNP in MxA Gene and the Responsiveness of Egyptian HCV Genotype 4 Patients to Pegylated Interferon and Ribavirin Treatment

scientific article

Change in the hepatic profile of hepatitis C virus genotype 4-infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE-II study

Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C.

scientific article

Determining the lower limit of detection required for HCV viral load assay for test of cure following direct‐acting antiviral‐based treatment regimens: Evidence from a global data set

scientific article published in 2022

Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients.

scientific article

Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.

scientific article published on 9 April 2018

Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients

scientific article published on 01 August 2018

Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients

scientific article published on 25 September 2017

Hepatitis C virus treatment by direct-acting antivirals in successfully treated hepatocellular carcinoma and possible mutual impact

scientific article published on 01 August 2018

How to optimize HCV therapy in genotype 4 patients.

scientific article published on February 2013

Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.

scientific article published on 25 July 2014

Initial experience of surgical microwave tissue precoagulation in liver resection for hepatocellular carcinoma in cirrhotic liver.

scientific article published on August 2014

Laparoscopic Radiofrequency Thermal Ablation of Hepatocellular Carcinoma in Liver Cirrhosis Patients

scientific article

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.

scientific article published on 17 April 2018

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care

scientific article

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial.

scientific article published on 16 June 2016

Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs. PEG-IFN alfa 2b; the debate continues.

scientific article published on February 2014

Planning and prioritizing direct acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience.

scientific article published on 6 December 2017

Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt.

scientific article published on 24 January 2011

Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience.

scientific article

Serum Vitamin D Levels in Treatment-naïve Chronic Hepatitis B Patients

scientific article published on 29 December 2017

Serum Zinc Deficiency and its Relation to Liver Fibrosis in Chronic HCV: a Real-Life Egyptian Study.

scientific article

Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis.

scientific article

Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4.

scientific article

Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt.

scientific article

Sofosbuvir-containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment

scientific article published on 20 December 2019

The future for the treatment of genotype 4 chronic hepatitis C.

scientific article published on February 2012

Paulina is supported by:

About Paulina

Help